Maesaka K, Hikita H, Kai M, Tahata Y, et al. Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma. J Gastroenterol Hepatol 2025 Sep 9. doi: 10.1111/jgh.70068.
PMID: 40922653